Submitted: 12 Apr 2015
Accepted: 13 May 2015
ePublished: 07 Jun 2015
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Ren Endocrinol. 2015;1: e07.
  Abstract View: 1392
  PDF Download: 1182


Hypomagnesemia and cisplatin nephrotoxicity

Hamid Nasri*

1 Nickan Research Institute, Isfahan, Iran.
*Corresponding Author: *Corresponding author: Professor Hamid Nasri, , Email: hamidnasri@med.mui.ac.ir

Please cite this paper as: Nasri H. Hypomagnesemia and cisplatin nephrotoxicity. J Renal Endocrinol. 2015;1:e07.

Implication for health policy/practice/research/medical education

Hypomagnesemia develops after cisplatin therapy and magnesium therapy is suggested to patients to prevent the hypomagnesemia after cisplatin therapy. Supplementation of magnesium may promote kidney toxicity of cisplatin, and therefore further studies are required to determine the exact role of magnesium in cisplatin metabolism.

First Name
Last Name
Email Address
Security code

Abstract View: 1393

Your browser does not support the canvas element.

PDF Download: 1182

Your browser does not support the canvas element.